China’s commerce ministry said on Thursday that it has conditionally approved a merger between U.S. medical equipment supplier Becton Dickinson (BDX.N) and its U.S. peer C R Bard (BCR.N).
In October, Becton Dickinson secured EU antitrust approval for its $24 billion acquisition of C R Bard after it agreed to sell two businesses to allay competition concerns.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.